17alpha-monooxygenase TAK-700, when used with other hormone therapy, may lessen the amount
of androgens made by the body. Radiation therapy uses high energy x rays to kill tumor
cells. This may be an effective treatment for prostate cancer when combined with hormone
therapy. Studying quality-of-life in patients having cancer treatment may help identify the
intermediate- and long-term effects of treatment on patients with prostate cancer.
PURPOSE: This randomized phase III trial is studying the use of hormone therapy, including
TAK-700, together with radiation therapy in treating patients with prostate cancer.
For more information about a clinical trial, clinical trial eligibility, or informed consent, contact our research nurses by phone or email:
- Cancer Help Line: (800) 639-6918
- Email: firstname.lastname@example.org
Please Note: Any eligibility criteria noted are subject to change. Our research nurses can provide you with the most current eligibility and exclusion criteria. Any study involvement to be undertaken must ultimately be determined on an individual basis.